This study will evaluate the benefit of lidocaine perfusion in cancer related visceral pain resistant to morphinics. It is an efficacy study in adults and children and a randomized prospective study.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
100
Institut Gustave-Roussy
Villejuif, France
RECRUITINGTo determine prospectively the lidocaine efficacy in 2 types of patient populations with cancer (group A: children from 6 to 14 years old and group B: adults from 15 to 70 years old)
Time frame: continuous intravenous perfusion for 6 days
To confirm the tolerance of the lidocaine
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.